Medicine Man Technologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Revenue	174.62	172.23	159.07	108.2	22.51	10.59
Other Revenue	0.29	0.22	0.3	0.23	1.49	0.03
Revenue	174.91	172.45	159.38	108.42	24	10.62
Revenue Growth (YoY)	5.55%	8.20%	47.00%	351.74%	126.03%	34.00%
Cost of Revenue	106.9	96.42	79.09	59.07	17.23	7.62
Gross Profit	68.01	76.02	80.29	49.35	6.77	3
Selling, General & Admin	77.79	67.36	56.75	33.91	21.45	9.19
Operating Expenses	78.98	70.93	59.42	38.94	29.68	16.62
Operating Income	-10.97	5.09	20.87	10.41	-22.9	-13.61
Interest Expense	-33.13	-32.07	-30.14	-7.01	-0.04	-0.16
Other Non Operating Income (Expenses)	6.55	15.94	18.44	15.06	1.3	-3.77
EBT Excluding Unusual Items	-37.55	-11.04	9.17	18.46	-21.65	-17.55
Impairment of Goodwill	-1.8	-1.8	-8.01	-	-	-
Gain (Loss) on Sale of Investments	-0.37	0	-0.04	0.22	-0.13	-1.79
Gain (Loss) on Sale of Assets	-1.97	-1.97	-4.68	0.24	-	-
Legal Settlements	-	-	-	-	-	1.78
Other Unusual Items	-	-	-	-	1.46	-
Pretax Income	-41.69	-14.81	-3.57	18.92	-20.32	-17.56
Income Tax Expense	17.99	19.74	14.9	4.4	-0.9	-0.58
Net Income	-59.68	-34.55	-18.47	14.52	-19.42	-16.98
Preferred Dividends & Other Adjustments	8.19	8.15	7.8	7.35	-	-
Net Income to Common	-67.86	-42.7	-26.27	7.17	-19.42	-16.98
Shares Outstanding (Basic)	74	65	54	43	41	34
Shares Outstanding (Diluted)	74	65	54	101	41	34
Shares Change (YoY)	28.04%	20.32%	-47.09%	145.94%	22.16%	21.50%
EPS (Basic)	-0.91	-0.66	-0.49	0.17	-0.47	-0.50
EPS (Diluted)	-0.91	-0.66	-0.49	-0.06	-0.47	-0.50
Free Cash Flow	1.28	4.34	-7.31	2.76	-10.57	-7.75
Free Cash Flow Per Share	0.02	0.07	-0.14	0.03	-0.26	-0.23
Gross Margin	38.88%	44.09%	50.38%	45.52%	28.23%	28.27%
Operating Margin	-6.27%	2.95%	13.09%	9.60%	-95.43%	-128.22%
Profit Margin	-38.80%	-24.76%	-16.48%	6.62%	-80.90%	-159.87%
Free Cash Flow Margin	0.73%	2.51%	-4.59%	2.54%	-44.03%	-73.02%
EBITDA	11.21	26.02	31.53	18.99	-22.43	-13.55
EBITDA Margin	6.41%	15.09%	19.78%	17.51%	-93.44%	-127.64%
D&A For EBITDA	22.18	20.93	10.66	8.58	0.48	0.06
EBIT	-10.97	5.09	20.87	10.41	-22.9	-13.61
EBIT Margin	-6.27%	2.95%	13.09%	9.60%	-95.43%	-128.22%
Effective Tax Rate	-	-	-	23.24%	-	-
Revenue as Reported	174.91	172.45	159.38	108.42	24	12.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.